LncRNA cancer susceptibility candidate 7 (CASC7) promoted the phosphorylation of glucocorticoid receptors to increase the sensitivity of glucocorticoids in patients with severe asthma by targeting the miR-21/phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signalling pathway. Here, AKT1 is linked to asthma.